Everybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where
Galmed Pharmaceuticals (GLMD) is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel,. Four other companies are scheduled for the week of March 10, 2014. The full
The full IPO calendar is available at IPOpremium. Scheduled IPOs are ranked by IPO size. (1) Based in Greenwich, CT, Diamond S Shipping Group (DSG) scheduled a $210 million IPO on the NYSE
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
Website: | www.galmedpharma.com |
Email: | info@galmedpharma.com |
Main Phone: | +972 36938448 |
Address: | 16 Tiomkin Street |
City / Town: | Tel Aviv |
Country: | IL |
Postal Code: | 6578317 |
Exchange: | NSC |
CEO: | Allen Baharaff |
Employees: | 24 |
NAICS: | Pharmaceutical P |
Everybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where
Galmed Pharmaceuticals (GLMD) is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel,. Four other companies are scheduled for the week of March 10, 2014. The full
The full IPO calendar is available at IPOpremium. Scheduled IPOs are ranked by IPO size. (1) Based in Greenwich, CT, Diamond S Shipping Group (DSG) scheduled a $210 million IPO on the NYSE
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |